JP2022502079A5 - - Google Patents
Info
- Publication number
- JP2022502079A5 JP2022502079A5 JP2021540778A JP2021540778A JP2022502079A5 JP 2022502079 A5 JP2022502079 A5 JP 2022502079A5 JP 2021540778 A JP2021540778 A JP 2021540778A JP 2021540778 A JP2021540778 A JP 2021540778A JP 2022502079 A5 JP2022502079 A5 JP 2022502079A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862733443P | 2018-09-19 | 2018-09-19 | |
| US201862733444P | 2018-09-19 | 2018-09-19 | |
| US201862733435P | 2018-09-19 | 2018-09-19 | |
| US62/733,444 | 2018-09-19 | ||
| US62/733,435 | 2018-09-19 | ||
| US62/733,443 | 2018-09-19 | ||
| PCT/US2019/051967 WO2020061337A1 (en) | 2018-09-19 | 2019-09-19 | Cancer associated antibody compositions and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022502079A JP2022502079A (ja) | 2022-01-11 |
| JPWO2020061337A5 JPWO2020061337A5 (https=) | 2022-11-01 |
| JP2022502079A5 true JP2022502079A5 (https=) | 2022-11-01 |
Family
ID=69888817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540778A Pending JP2022502079A (ja) | 2018-09-19 | 2019-09-19 | がん関連抗体組成物および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12285484B2 (https=) |
| EP (1) | EP3853377A4 (https=) |
| JP (1) | JP2022502079A (https=) |
| AU (1) | AU2019342131A1 (https=) |
| CA (1) | CA3113223A1 (https=) |
| WO (1) | WO2020061337A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116348483A (zh) * | 2020-07-31 | 2023-06-27 | 南特生物公司 | 嵌合t细胞受体，核酸及其制造和使用方法 |
| CN116635948A (zh) * | 2020-12-07 | 2023-08-22 | Absci公司 | 用于产生疾病相关蛋白质组合物的系统和方法 |
| CN114106187B (zh) * | 2022-01-05 | 2023-01-24 | 中国海洋大学 | 一种靶向ogt的特异性鲨鱼单域抗体及其制备方法和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0124317D0 (en) | 2001-10-10 | 2001-11-28 | Celltech R&D Ltd | Biological products |
| MX2007008719A (es) | 2005-01-27 | 2007-09-11 | Novimmune Sa | Anticuerpos anti-interferon gamma y metodos de uso de los mismos. |
| US8759490B2 (en) * | 2005-03-24 | 2014-06-24 | Millennium Pharamaceuticals, Inc. | Antibodies that bind OV064 and methods of use therefor |
| WO2008063346A2 (en) * | 2006-10-26 | 2008-05-29 | The Research Foundation Of State University Of New York | IL-14α RNA INHIBITORS AND ANTIBODIES TO IL-14α FOR TREATMENT OF AUTOIMMUNE DISEASES AND LYMPHOMAS |
| US20090304590A1 (en) | 2007-05-29 | 2009-12-10 | Wyeth | Therapeutic compositions and methods |
| US7763261B2 (en) | 2007-12-19 | 2010-07-27 | Dcb-Usa Llc | Anti-human cytomegalovirus antibodies |
| PL2606064T3 (pl) | 2010-08-16 | 2015-07-31 | Novimmune Sa | Sposoby wytwarzania wieloswoistych i wielowartościowych przeciwciał |
| PT3277821T (pt) | 2015-03-31 | 2019-10-31 | Novimmune Sa | Método para otimizar a montagem e produção de complexos proteicos hetero-multiméricos |
| CA2988912C (en) | 2015-06-10 | 2023-09-12 | National Research Council Of Canada | Carbonic anhydrase ix-specific antibodies and uses thereof |
| EP3332637A1 (en) * | 2016-12-09 | 2018-06-13 | Universitätsklinikum Hamburg-Eppendorf | Vhh-containing heavy chain antibody and production thereof |
-
2019
- 2019-09-19 CA CA3113223A patent/CA3113223A1/en active Pending
- 2019-09-19 JP JP2021540778A patent/JP2022502079A/ja active Pending
- 2019-09-19 AU AU2019342131A patent/AU2019342131A1/en not_active Abandoned
- 2019-09-19 WO PCT/US2019/051967 patent/WO2020061337A1/en not_active Ceased
- 2019-09-19 US US17/277,214 patent/US12285484B2/en active Active
- 2019-09-19 EP EP19861397.8A patent/EP3853377A4/en active Pending